Long-Term Study Confirms Safety and Effectiveness of Rivaroxaban for Children

Long-term study confirms safety and effectiveness of rivaroxaban for children

Venous thromboembolism (VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer.

Venous thromboembolism in children: Rivaroxaban found effective and safe even with extended use

Venous thromboembolism (VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer. Treatment or prevention of thrombosis poses an additional challenge in everyday clinical practice. A therapy using the active ingredient rivaroxaban specifically tailored to children was successfully tested for the first time in 2020.

Rivaroxaban Proves Safe and Effective for Extended Use in Treating Venous

Venous thromboembolism (VTE) in pediatric populations represents a formidable clinical challenge, especially among children suffering from serious underlying medical conditions such as congenital heart defects or malignancies. The pathophysiology of VTE involves the formation of blood clots within deep veins, resulting in either local vascular obstruction or embolization of thrombotic material to the pulmonary arteries, potentially precipitating…

Venous thromboembolism in children: Rivaroxaban effective and safe even with extended use